Angiodynamics (ANGO) Other Non-Current Assets (2011 - 2026)
Angiodynamics' (ANGO) quarterly Other Non-Current Assets came in at $9.5 million in Q2 2026, down 9.04% YoY from $10.4 million in Q2 2025, and down 9.86% on a QoQ basis from $10.5 million in Q1 2026.
Angiodynamics (ANGO) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 16 years of Other Non-Current Assets data on file, last reported at $9.5 million in Q2 2026.
- Quarterly Other Non-Current Assets fell 9.04% year-over-year to $9.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $9.5 million (down 9.04% YoY) and the FY2026 annual result came in at $9.5 million, down 9.04% from the prior year.
- Other Non-Current Assets retreated to $9.5 million in Q2 2026, from $10.5 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $43.7 million in Q2 2023 to a low of $9.5 million in Q2 2026.
- A 5-year average of $12.8 million and a median of $10.7 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 298.18% — and 2024, when it slumped 73.96%.
- Tracing ANGO's Other Non-Current Assets over 5 years: stood at $10.7 million in 2022, then jumped by 307.13% to $43.7 million in 2023, then plunged by 76.86% to $10.1 million in 2024, then grew by 9.6% to $11.1 million in 2025, then slipped by 14.54% to $9.5 million in 2026.
- The last three Other Non-Current Assets figures came in at $9.5 million (Q2 2026), $10.5 million (Q1 2026), and $11.1 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Angiodynamics | 655.49 Mn | 601.62 Mn | 46.77 Mn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 9.46 Mn |
| Feb 28, 2026 | 10.50 Mn |
| Nov 30, 2025 | 11.07 Mn |
| Aug 31, 2025 | 9.54 Mn |
| May 31, 2025 | 10.40 Mn |
| Feb 28, 2025 | 9.68 Mn |
| Nov 30, 2024 | 10.10 Mn |
| Aug 31, 2024 | 10.88 Mn |
| May 31, 2024 | 11.37 Mn |
| May 31, 2023 | 43.65 Mn |
| Feb 28, 2023 | 10.73 Mn |
| Nov 30, 2022 | 10.72 Mn |
| Aug 31, 2022 | 11.08 Mn |
| May 31, 2022 | 10.96 Mn |
| Feb 28, 2022 | 11.31 Mn |
| Nov 30, 2021 | 12.12 Mn |
| Aug 31, 2021 | 12.93 Mn |
| May 31, 2021 | 13.19 Mn |
| Feb 28, 2021 | 19.44 Mn |
| Nov 30, 2020 | 17.51 Mn |